Decision letter for "Efsubaglutide Alfa in Adults With Overweight or Obesity: Protocol for a Seamless, Adaptive Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled Trial (LIGHT 2)"

Publons reviews and discussion 2026

View at publisher

DOI: 10.1111/dom.70556/v2/decision1

Cited by: 0

Fields of Study & Subjects

Pharmacology and Obesity Treatment Diabetes Treatment and Management Adipokines Inflammation and Metabolic Diseases